< Back

logo logo

Johannes Fruehauf, MD, PhD

Co-founder, President

CEO, Cambridge Biolabs and ViThera Pharma; Cofounder, Cequent Pharmaceuticals

Johannes Fruehauf (MD PhD) has a background as a physician working in diverse health systems. In his 15+ years as a serial biotech entrepreneur, Dr. Fruehauf has dedicated much of his professional endeavors to the mission of re-defining life science entrepreneurship and building start-up ecosystems. 

He is the Founder and President of LabCentral, the preeminent private/public partnership model for life science incubator space, while also serving as CEO for BioLabs, the largest provider of laboratory co-working space for startups nationwide. LabCentral and Biolabs currently are home for over 300 startups in 8 cities and companies started within this network now routinely account for over 20% of all Seed and Series A venture capital invested in life sciences in the US.

Johannes is founder and General Partner of Mission BioCapital (MBC). In his role at MBC, he sources, diligences, and leads new life-science investment transactions and represents the fund on the board of a number of MBC portfolio companies.

Dr. Fruehauf studied medicine in Germany and France, while also conducting field work in Africa (Zimbabwe and Guinea). He graduated from University of Frankfurt and received his doctorate from the University of Heidelberg. Johannes is the author of over 30 peer reviewed publications and is named inventor on 9 patents.

Favorite school science project: “Anything that would explode!  Electrolytic preparation of oxyhydrogen and I also built cannons with black powder.”